These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9326477)

  • 1. Endothelial activation and development of coronary artery disease in transplanted human hearts.
    Labarrere CA; Nelson DR; Faulk WP
    JAMA; 1997 Oct; 278(14):1169-75. PubMed ID: 9326477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study.
    Labarrere CA; Lee JB; Nelson DR; Al-Hassani M; Miller SJ; Pitts DE
    Lancet; 2002 Nov; 360(9344):1462-7. PubMed ID: 12433514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.
    Labarrere CA; Pitts D; Nelson DR; Faulk WP
    N Engl J Med; 1995 Oct; 333(17):1111-6. PubMed ID: 7565949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endomyocardial biopsies. An early warning system for chronic transplant arteriopathy.
    Aretz HT; Colvin RB
    JAMA; 1997 Oct; 278(14):1197-8. PubMed ID: 9326484
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary artery disease in cardiac allografts: association with arteriolar endothelial HLA-DR and ICAM-1 antigens.
    Labarrere CA; Pitts D; Nelson DR; Faulk WP
    Transplant Proc; 1995 Jun; 27(3):1939-40. PubMed ID: 7792843
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients.
    Labarrere CA; Nelson DR; Faulk WP
    Am J Med; 1998 Sep; 105(3):207-13. PubMed ID: 9753023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure.
    Labarrere CA; Nelson DR; Miller SJ; Nieto JM; Conner JA; Pitts DE; Kirlin PC; Halbrook HG
    Circulation; 2000 Sep; 102(13):1549-55. PubMed ID: 11004146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical model to predict risk for coronary artery disease and failure in heart transplant patients.
    Labarre CA; Nelson DR; Pitts DE; Kirlin PC; Halbrook H
    Am J Transplant; 2001 Sep; 1(3):251-9. PubMed ID: 12102259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of adhesion molecules in myocardial biopsies of cardiac allografts and coronary artery disease with CABG.
    Lehmkuhl H; Horn C; von der Driesch P; Kämmerer U; Müller T; von der Emde J; Olbrich HG; Kunkel B; Bachmann K
    J Cardiovasc Surg (Torino); 1996 Dec; 37(6 Suppl 1):65-70. PubMed ID: 10064353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts.
    Tanaka H; Sukhova GK; Swanson SJ; Cybulsky MI; Schoen FJ; Libby P
    Am J Pathol; 1994 May; 144(5):938-51. PubMed ID: 7513950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
    Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation.
    Labarrere CA; Nelson DR; Cox CJ; Pitts D; Kirlin P; Halbrook H
    JAMA; 2000 Jul; 284(4):457-64. PubMed ID: 10904509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular antithrombin and clinical outcome in heart transplant patients.
    Labarrere CA; Torry RJ; Nelson DR; Miller SJ; Pitts DE; Kirlin PC; Halbrook HG
    Am J Cardiol; 2001 Feb; 87(4):425-31. PubMed ID: 11179526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts.
    Faulk WP; Rose M; Meroni PL; Del Papa N; Torry RJ; Labarrere CA; Busing K; Crisp SJ; Dunn MJ; Nelson DR
    Hum Immunol; 1999 Sep; 60(9):826-32. PubMed ID: 10527389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation.
    Ballantyne CM; Masri BM; Clubb FJ; Radovancević B; Smith CW; Hawkins HK; Frazier OH; Willerson JT
    Tex Heart Inst J; 1996; 23(4):293-5. PubMed ID: 8969030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct expression of cell-cell and cell-matrix adhesion molecules on endothelial cells in human heart and lung transplants.
    Steinhoff G; Behrend M; Richter N; Schlitt HJ; Cremer J; Haverich A
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1145-55. PubMed ID: 8719462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.
    Salomon RN; Hughes CC; Schoen FJ; Payne DD; Pober JS; Libby P
    Am J Pathol; 1991 Apr; 138(4):791-8. PubMed ID: 2012171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    Transpl Int; 1993; 6(6):341-7. PubMed ID: 8297464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.